NASDAQ:CBUS Cibus (CBUS) Stock Price, News & Analysis $2.75 -0.08 (-2.83%) Closing price 05/21/2025 04:00 PM EasternExtended Trading$2.74 -0.01 (-0.36%) As of 04:45 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock About Cibus Stock (NASDAQ:CBUS) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Cibus alerts:Sign Up Key Stats Today's Range$2.62▼$2.9050-Day Range$1.52▼$3.1252-Week Range$1.40▼$16.36Volume186,000 shsAverage Volume177,842 shsMarket Capitalization$89.85 millionP/E RatioN/ADividend YieldN/APrice Target$22.00Consensus RatingBuy Company OverviewCibus, Inc., a agricultural biotechnology company, develops and licenses plant traits to seed companies for royalties. The company primarily focus on trait productivity in two areas, including productivity traits that enable farmers to have higher yields and reduce the use of the crop protection chemicals and fertilizers; and sustainable ingredients that enable corporations to replace ingredients that are fossil fuel based or whose production results in increased greenhouse gases. Cibus, Inc. is based in San Diego, California.Read More… Cibus Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks32nd Percentile Overall ScoreCBUS MarketRank™: Cibus scored higher than 32% of companies evaluated by MarketBeat, and ranked 109th out of 147 stocks in the consumer staples sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion3.6 / 5Analyst RatingBuy Consensus RatingCibus has received a consensus rating of Buy. The company's average rating score is 3.25, and is based on 3 buy ratings, no hold ratings, and no sell ratings.Amount of Analyst CoverageCibus has only been the subject of 2 research reports in the past 90 days.Read more about Cibus' stock forecast and price target. Earnings and Valuation0.6 / 5Proj. Earnings GrowthDecreasing Earnings GrowthEarnings for Cibus are expected to decrease in the coming year, from ($2.96) to ($3.02) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Cibus is -0.12, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Cibus is -0.12, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioCibus has a P/B Ratio of 0.22. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities. Short Interest0.0 / 5Short Interest LevelBearish Percentage of Shares Shorted10.26% of the float of Cibus has been sold short.Short Interest Ratio / Days to CoverCibus has a short interest ratio ("days to cover") of 15.4, which indicates bearish sentiment.Change versus previous monthShort interest in Cibus has recently increased by 13.94%, indicating that investor sentiment is decreasing significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldCibus does not currently pay a dividend.Dividend GrowthCibus does not have a long track record of dividend growth. Sustainability and ESGN/AEnvironmental ScoreN/A Percentage of Shares Shorted10.26% of the float of Cibus has been sold short.Short Interest Ratio / Days to CoverCibus has a short interest ratio ("days to cover") of 15.4, which indicates bearish sentiment.Change versus previous monthShort interest in Cibus has recently increased by 13.94%, indicating that investor sentiment is decreasing significantly. News and Social Media1.1 / 5News Sentiment0.00 News Coverage This WeekMarketBeat has tracked 3 news articles for Cibus this week, compared to 3 articles on an average week.Search Interest1 people have searched for CBUS on MarketBeat in the last 30 days. MarketBeat Follows1 people have added Cibus to their MarketBeat watchlist in the last 30 days. Company Ownership2.5 / 5Insider TradingSelling Shares Insider Buying vs. Insider SellingIn the past three months, Cibus insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $2,380.00 in company stock.Percentage Held by Insiders31.16% of the stock of Cibus is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by InstitutionsOnly 33.81% of the stock of Cibus is held by institutions.Read more about Cibus' insider trading history. Receive CBUS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Cibus and its competitors with MarketBeat's FREE daily newsletter. Email Address CBUS Stock News HeadlinesCibus, Inc. to Present Advances in Gene-Editing Technology at AGP Annual Virtual Healthcare Company ShowcaseMay 21 at 11:06 PM | nasdaq.comCibus to Participate in Alliance Global Partner’s Annual Virtual Healthcare Company ShowcaseMay 20 at 11:58 AM | finance.yahoo.comAI Meltdown Imminent: Dump These Stocks Now!If you have any money in the markets, especially in AI stocks… Please click here to see Elon Musk’s new invention… This could send many popular AI stocks crashing, including Nvidia. And it could happen starting as soon as June 1st.May 22, 2025 | Paradigm Press (Ad)Cibus to Participate in Alliance Global Partner's Annual Virtual Healthcare Company ShowcaseMay 19 at 4:05 PM | globenewswire.comCibus, Inc. (CBUS) Q1 2025 Earnings Call TranscriptMay 10, 2025 | seekingalpha.comCibus, Inc. (NASDAQ:CBUS) Q1 2025 Earnings Call TranscriptMay 10, 2025 | msn.comCibus, Inc. Earnings Call: Achievements and ChallengesMay 9, 2025 | tipranks.comCibus Reports First Quarter Financial Results and Provides Year-to-Date Business Update for 2025May 8, 2025 | globenewswire.comSee More Headlines CBUS Stock Analysis - Frequently Asked Questions How have CBUS shares performed this year? Cibus' stock was trading at $2.78 at the beginning of the year. Since then, CBUS stock has decreased by 1.1% and is now trading at $2.75. View the best growth stocks for 2025 here. How were Cibus' earnings last quarter? Cibus, Inc. (NASDAQ:CBUS) announced its quarterly earnings results on Thursday, May, 8th. The company reported ($0.74) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.70) by $0.04. The company earned $1.03 million during the quarter, compared to analysts' expectations of $1.15 million. Cibus had a negative trailing twelve-month return on equity of 28.17% and a negative net margin of 10,724.78%. When did Cibus IPO? Cibus (CBUS) raised $100 million in an initial public offering on Thursday, February 14th 2019. The company issued 6,700,000 shares at $14.00-$16.00 per share. Morgan Stanley, BofA Merrill Lynch and Piper Jaffray acted as the underwriters for the IPO. Who are Cibus' major shareholders? Top institutional investors of Cibus include Armistice Capital LLC (5.93%), Certior Financial Group LLC (0.45%), Charles Schwab Investment Management Inc. (0.17%) and Goldman Sachs Group Inc. (0.15%). Insiders that own company stock include Gregory Francis William Gocal, Carlo Broos and Gerhard Prante. View institutional ownership trends. How do I buy shares of Cibus? Shares of CBUS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Cibus own? Based on aggregate information from My MarketBeat watchlists, some other companies that Cibus investors own include NVIDIA (NVDA), Tesla (TSLA), Meta Platforms (META), Advanced Micro Devices (AMD), Visa (V), Netflix (nflx) and JPMorgan Chase & Co. (JPM). Company Calendar Last Earnings5/08/2025Today5/21/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorConsumer Staples Industry Agricultural chemicals Sub-IndustryChemicals Current SymbolNASDAQ:CBUS CIK1705843 Webwww.calyxt.com Phone(858) 450-0008FaxN/AEmployees48Year FoundedN/APrice Target and Rating Average Stock Price Target$22.00 High Stock Price Target$25.00 Low Stock Price Target$17.50 Potential Upside/Downside+700.0%Consensus RatingBuy Rating Score (0-4)3.25 Research Coverage4 Analysts Profitability EPS (Most Recent Fiscal Year)($10.98) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-267,640,000.00 Net Margins-10,724.78% Pretax Margin-12,860.54% Return on Equity-28.17% Return on Assets-13.39% Debt Debt-to-Equity RatioN/A Current Ratio1.44 Quick Ratio1.44 Sales & Book Value Annual Sales$4.75 million Price / Sales18.91 Cash Flow$9.82 per share Price / Cash Flow0.28 Book Value$12.38 per share Price / Book0.22Miscellaneous Outstanding Shares32,672,000Free Float13,387,000Market Cap$89.85 million OptionableOptionable Beta1.70 10 Stocks Set to Soar in Spring 2025Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Spring 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.Get This Free Report This page (NASDAQ:CBUS) was last updated on 5/22/2025 by MarketBeat.com Staff From Our PartnersJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | SponsoredA new financial chapter Porter Stansberry says what happened last week could become the defining legacy of his financial publishing ca...Porter & Company | SponsoredThe Secret Map of America, Declassified…Locked inside a Maryland man’s private safe is a map. But not just any map, mind you… This map shows a “...Banyan Hill Publishing | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredElon’s backup plan for AIElon knows the future isn’t about smarter AI — it’s about powering it. And this new technology is quietly b...True Market Insiders | SponsoredExclusive Offer: Target 100% Returns NowBrace yourself–this may come as a shock. It turns out that you may not have to wait decades to turn a small...ProsperityPub | SponsoredPrepare now for May 31 eventPrepare now for May 31 event Circle May 31 on your calendar This man grew up in a trailer in New Mexico. To...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cibus, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cibus With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.